Details for 2018169942

Up to date per 01.04.2026

Actions

Title / Product Name

MENSCHLICHES CD30-LIGANDANTIGEN BINDENDE PROTEINE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018169942

EP Publication Number

3431492

E-Number

1347632

Language

PCT Number

Publication Date

23.01.2019 A

23.12.2020 B1

Registration Date

23.12.2020

AT Publication Date

15.01.2021

Application Date

25.04.2013

Registration Number

Priorities

27.04.2012

201261639637 P

IPC

C07K 14/28 20060101AFI20200610BHEP

Maximum Duration of Protection

25.04.2033

Owner

Novo Nordisk A/SNovo Allé 2880 BagsværdDK

Amgen Inc.One Amgen Center Drive Thousand Oaks, California 91320-1799US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

ANDERSEN, Mette DahlNovo Nordisk A/S Novo Allé 2880 BagsværdDK

DANTZLER, Jeff14012 Wayne Pl. N. Seattle, WA 98133US

ARMITAGE, Richard J.5840 Packard Lane Bainbridge Island, WA 98110US

CLARK, Rutilio5335 Old Mill Road NE Bainbridge Island, WA 98110US

Information about Fees